Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 50: 1383-1390, 2004. First published May 20, 2004; 10.1373/clinchem.2004.032862
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2004.032862v1
50/8/1383    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sieg, A.
Right arrow Articles by Delgado-Charro, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sieg, A.
Right arrow Articles by Delgado-Charro, M. B.
Related Collections
Right arrow Endocrinology and Metabolism
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2004;50:1383-1390.)
© 2004 American Association for Clinical Chemistry, Inc.

Endocrinology and Metabolism

Noninvasive Glucose Monitoring by Reverse Iontophoresis in Vivo: Application of the Internal Standard Concept

Anke Sieg1,2, Richard H. Guy1,2 and M. Begoña Delgado-Charro1,2,a

1 University of Geneva, School of Pharmacy, Geneva, Switzerland. 2 Centre Interuniversitaire de Recherche et d’Enseignement, "Pharmapeptides", Campus Universitaire, Archamps, France.

aAddress correspondence to this author at: University of Geneva, School of Pharmacy, Quai Ernest-Ansermet 30, CH-1211 Geneva, Switzerland. Fax 33-450-95-28-32; e-mail Begonia.Delgado{at}pharm.unige.ch.

Background: The GlucoWatch® Biographer uses reverse iontophoresis to extract glucose across the skin to monitor glycemia in diabetes. The invasive daily calibration with a conventional "fingerstick" has been perceived as a disadvantage. We used an "internal standard" to render the approach completely noninvasive.

Methods: The simultaneous extraction of glucose and sodium by reverse iontophoresis was performed on human volunteers over 5 h, and blood glucose was measured in the conventional manner at each collection interval. These data were used for each volunteer to calculate an extraction constant (K), which equals the ratio of the extracted fluxes (JGlucose/JNa+) normalized by the corresponding ratio of the concentrations in the blood ([Glucose]/[Na+]). The values of K were compared between and within volunteers.

Results: The iontophoretically extracted glucose flux reflected the glucose concentration profiles in the blood, and sodium extraction remained essentially constant, consistent with the fact that its systemic concentration does not vary significantly. A constant value of K was established for two thirds of the study population. However, the efficiency of glucose extraction varied seasonally, whereas the reverse iontophoresis of Na+ did not; i.e., variation in K became apparent.

Conclusions: Use of the sodium ion as an internal standard could refine the determination of glycemia by reverse iontophoresis without requiring calibration with a blood sample.




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
F. M. Musteata, M. L. Musteata, and J. Pawliszyn
Fast In Vivo Microextraction: A New Tool for Clinical Analysis
Clin. Chem., April 1, 2006; 52(4): 708 - 715.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Association for Clinical Chemistry.